The position statement issued by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) on the management of hyperglycemia in T2DM states that the HbA_1C level should be maintained at <7%, with a preprandial or fasting glucose goal of <130 mg/dL and a postprandial glucose goal of ≤180 mg/dL.[2]  The key point is to individualize treatment goals for the patient in front of you, with slightly tighter HbA_1C targets for the younger, healthier patients and slightly more relaxed HbA_1C targets for older patients, who may have many more comorbidities or more risk of hypoglycemia, for example.  For these latter patients the HbA_1C target might be between 7.5% and 8%, since the goal is to keep their risk of hypoglycemia very low at all cost and indeed to try to avoid hypoglycemia altogether.  Kapustin J. J Nurse Pract. 2014; 00:00 – 00.